Literature DB >> 30285147

Infant nocturnal wakefulness: a longitudinal study comparing three sleep assessment methods.

Liat Tikotzky1, Ella Volkovich1.   

Abstract

Study
Objectives: To examine the convergence between actigraphy, sleep diaries, and the Brief Infant Sleep Questionnaire (BISQ) in the assessment of infant nocturnal wakefulness (i.e. minutes awake after sleep onset [WASO] and number of night-wakings [NW]) in the context of a longitudinal study.
Methods: The sample included 226 families, who were recruited during pregnancy. Data were collected at 3, 6, 12, and 18 months postpartum. Infants' sleep was monitored at home for five nights using actigraphy, sleep diaries, and the BISQ. Outcome measures included WASO and NW, as well as sleep latency, sleep duration, and sleep onset.
Results: Trajectory analyses demonstrated that all three methods showed declines in NW and WASO from 3 to 18 months. Statistically significant correlations were found between the three methods at all assessment points for all sleep variables. However, agreement rates (using Krippendorff's α and Bland-Altman analyses) between actigraphy and parental reports were poor. For NW, agreement between actigraphy and parental reports at 18 months was lower than that at 3 and 6 months. Diaries and BISQ showed satisfactory agreement for sleep latency. Conclusions: Although the three methods' measures of infant nocturnal wakefulness are significantly correlated during infancy, absolute agreement between these methods is poor overall. The growing disagreement between actigraphy and parental reports (in NW) across development probably suggests that parents become less aware of infants' awakenings, due to the increasing ability of infants to self-soothe. Using both objective and subjective assessment methods seems especially important after the age of 6 months.

Entities:  

Year:  2019        PMID: 30285147     DOI: 10.1093/sleep/zsy191

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  7 in total

1.  Nighttime sleep and physical activity in 6-7 month-old infants.

Authors:  Agnes G Bucko; Marsha Dowda; Edward A Frongillo; Myriam E Torres; Russell R Pate
Journal:  Infant Behav Dev       Date:  2021-08-12

2.  Effect of Play2Sleep on mother-reported and father-reported infant sleep: a sequential explanatory mixed-methods study of a randomized controlled trial.

Authors:  Elizabeth M Keys; Karen M Benzies; Valerie G Kirk; Linda Duffett-Leger
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

3.  Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial.

Authors:  Yulin Sun; Weiwei Feng; Jian Chen; Miao Liu; Xiuyu Shi; Jing Wang; Liping Zou; Tao Xu; Guang Yang
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

4.  Behavioral interventions for infant sleep problems: the role of parental cry tolerance and sleep-related cognitions.

Authors:  Michal Kahn; Efrat Livne-Karp; Michal Juda-Hanael; Haim Omer; Liat Tikotzky; Thomas F Anders; Avi Sadeh
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

Review 5.  Actigraphy in sleep research with infants and young children: Current practices and future benefits of standardized reporting.

Authors:  Sarah F Schoch; Salome Kurth; Helene Werner
Journal:  J Sleep Res       Date:  2020-07-08       Impact factor: 3.981

6.  Concordance between subjective and objective measures of infant sleep varies by age and maternal mood: Implications for studies of sleep and cognitive development.

Authors:  L K Gossé; F Wiesemann; C E Elwell; E J H Jones
Journal:  Infant Behav Dev       Date:  2021-11-23

Review 7.  A systematic review of proxy-report questionnaires assessing physical activity, sedentary behavior and/or sleep in young children (aged 0-5 years).

Authors:  Jelle Arts; Jessica S Gubbels; Arnoud P Verhoeff; Mai J M Chinapaw; Annelinde Lettink; Teatske M Altenburg
Journal:  Int J Behav Nutr Phys Act       Date:  2022-02-14       Impact factor: 6.457

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.